We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+5.29%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$39.5B
AUM Growth
+$3.17B
(+8.7%)
Cap. Flow
+$1.77B
Cap. Flow
% of AUM
4.5%
Top 10 Holdings %
Top 10 Hldgs %
14.6%
Holding
2,920
New
47
Increased
1,798
Reduced
994
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$26.1M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$22M |
| 3 |
Apple
AAPL
|
+$20.6M |
| 4 |
Microsoft
MSFT
|
+$18.3M |
| 5 |
AT&T
T
|
+$15.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LNKD
LinkedIn Corporation
LNKD
|
+$24.4M |
| 2 |
Procter & Gamble
PG
|
+$21.2M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$19.7M |
| 4 |
Alcoa
AA
|
+$17.9M |
| 5 |
Yum! Brands
YUM
|
+$15.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.57% |
| 2 | Technology | 14.46% |
| 3 | Healthcare | 12.77% |
| 4 | Industrials | 10.91% |
| 5 | Consumer Discretionary | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
1551
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.69M | ﹤0.01% |
37,935
+3,612
| +11% | +$127K |
|
|
SONC
1552
DELISTED
Sonic Corp
SONC
| $1.68M | ﹤0.01% |
63,516
+737
| +1% | +$19.2K |
|
|
NTUS
1553
DELISTED
Natus Medical Inc
NTUS
| $1.68M | ﹤0.01% |
48,317
+1,860
| +4% | +$73K |
|
|
SYKE
1554
DELISTED
SYKES Enterprises Inc
SYKE
| $1.68M | ﹤0.01% |
58,203
-2,682
| -4% | -$74.8K |
|
|
GCI
1555
DELISTED
Gannett Co., Inc
GCI
| $1.68M | ﹤0.01% |
172,867
-5,662
| -3% | -$55.4K |
|
1556
Helix Energy Solutions
HLX
$1.4B
| $1.68M | ﹤0.01% |
190,038
+7,109
| +4% | +$68.6K |
|
1557
Sturm, Ruger & Co
RGR
$594M
| $1.67M | ﹤0.01% |
31,751
-115
| -0.4% | -$6.35K |
|
1558
Scansource
SCSC
$1.15B
| $1.67M | ﹤0.01% |
41,446
-2,394
| -5% | -$89.1K |
|
|
FCB
1559
DELISTED
FCB Financial Holdings, Inc.
FCB
| $1.67M | ﹤0.01% |
35,032
-713
| -2% | -$29.5K |
|
1560
Global Net Lease
GNL
$1.84B
| $1.66M | ﹤0.01% |
70,858
+4,627
| +7% | +$106K |
|
|
FCH
1561
DELISTED
Felcor Lodging Trust
FCH
| $1.66M | ﹤0.01% |
206,783
+9,945
| +5% | +$70.5K |
|
|
GIMO
1562
DELISTED
Gigamon Inc.
GIMO
| $1.65M | ﹤0.01% |
36,232
+2,294
| +7% | +$119K |
|
1563
SPS Commerce
SPSC
$2.64B
| $1.65M | ﹤0.01% |
47,162
+2,286
| +5% | +$78.1K |
|
1564
Supernus Pharmaceuticals
SUPN
$2.59B
| $1.65M | ﹤0.01% |
65,199
+4,151
| +7% | +$92.8K |
|
|
FPRX
1565
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.65M | ﹤0.01% |
32,828
+338
| +1% | +$17.8K |
|
|
ENV
1566
DELISTED
ENVESTNET, INC.
ENV
| $1.64M | ﹤0.01% |
46,607
+2,406
| +5% | +$86.3K |
|
|
MSGN
1567
DELISTED
MSG Networks Inc.
MSGN
| $1.64M | ﹤0.01% |
76,281
-1,508
| -2% | -$30K |
|
1568
City Holding Co
CHCO
$2.05B
| $1.64M | ﹤0.01% |
24,201
-678
| -3% | -$39.4K |
|
|
BEL
1569
DELISTED
Belmond Ltd.
BEL
| $1.63M | ﹤0.01% |
122,364
-7,501
| -6% | -$96.4K |
|
|
FFG
1570
DELISTED
FBL Financial Group
FFG
| $1.63M | ﹤0.01% |
20,892
-323
| -2% | -$23.2K |
|
|
AYR
1571
DELISTED
Aircastle Ltd
AYR
| $1.63M | ﹤0.01% |
78,126
-3,236
| -4% | -$68.3K |
|
|
KG
1572
Kestrel Group
KG
$69.4M
| $1.63M | ﹤0.01% |
4,666
+391
| +9% | +$120K |
|
|
TBI
1573
Trueblue
TBI
$215M
| $1.62M | ﹤0.01% |
65,836
-2,227
| -3% | -$46.9K |
|
|
BNCL
1574
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $1.62M | ﹤0.01% |
87,822
-5,327
| -6% | -$87.1K |
|
1575
Standex International
SXI
$3.59B
| $1.61M | ﹤0.01% |
18,362
-29
| -0.2% | -$2.53K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2016 Portfolio in Review
As of Q4 2016, RhumbLine Advisers held 2,920 positions worth $39.5B, up 8.7% from $36.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.77B of net new capital in Q4 2016, opening 47 new positions and adding to 1,798 existing holdings. Its largest new stake was Howmet Aerospace: 952,104 shares worth $13.5M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $21.2M trimmed.
- RhumbLine Advisers's largest Q4 2016 buy was Howmet Aerospace: 952,104 shares worth $13.5M.
- RhumbLine Advisers added most to ExxonMobil in Q4 2016, an estimated $26.1M increase.
- RhumbLine Advisers's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $21.2M.
- RhumbLine Advisers fully exited LinkedIn Corporation in Q4 2016, selling an estimated $24.4M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $39.5B portfolio in Q4 2016.
- RhumbLine Advisers opened 47 new positions and closed 66 in Q4 2016.
- RhumbLine Advisers's portfolio value rose 8.7% quarter-over-quarter to $39.5B.
Based on RhumbLine Advisers's 13F filing for Q4 2016, filed 27 Jan 2017.